Displaying 1 to 9 of 9 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Acologix Inc Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment. |
United States | 4 May 2004 | Series B Led the investment round. Active |
|
|
|
Albireo AB |
Sweden | N/A |
||
|
|
ARYx Therapeutics Inc |
United States | N/A Active |
||
|
|
Cerimon Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs. |
United States | N/A |
||
|
|
Equator Technologies Inc |
United States | N/A |
||
|
|
Pharmion Corp Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. |
United States | N/A |
||
|
R3 HoldCo LLC Developer of distributed software and enterprise technology for capital markets, financial services and other regulated industries. |
United States | 24 May 2017 | Series A Initial investment. Round participant. Active |
|
|
|
R3 HoldCo LLC Developer of distributed software and enterprise technology for capital markets, financial services and other regulated industries. |
United States | 31 May 2018 | N/A Initial investment. Round participant. Active |
|
|
|
Sequenom Inc Biotechnology tools and diagnostics company. |
United States | N/A |